Patient and public involvement (PPI) in setting the research agenda Dr Noémi Roy Oxford Molecular Haematology.

Slides:



Advertisements
Similar presentations
Building Your Program Club Planning Activities. Need to put it together Members have evaluated Community Needs have been reviewed You know what makes.
Advertisements

Implementing NICE guidance
Service user participation in clinical trials Partnership or Co-option? Dr. Jan Wallcraft Operational Manager of SURGE (Service User Research Group for.
Post Research Benefits Mandika Wijeyaratne MS, MD, FRCS Dept. of Surgery, Colombo.
Philanthropy, Values and Citizenship
Definitions Patient Experience Patient experience at NUH results from a range of activities that all impact upon patient care, access, safety and outcomes.
Experiences of Patient and Public involvement in the Research Process Roma Maguire Senior Research Fellow Cancer Care Research Team School of Nursing and.
1. Choosing outcomes and measures - for doing and using research James Lind Alliance Outcomes in clinical research – whose responsibility? 20 November.
S3 Useful Expressions.
Hampshire Children’s Services Personalisation and Personal Budgets Pilot A Parent and Carer Guide.
Highly Specialised Technologies Evaluations
Building Rapport Interpersonal skills of care workers were as important as practical skills and knowing how to do the job. Having a positive attitude could.
IBD PATIENT PANELS IBD Patient Panel Surveys Why Carry Out a Survey?  Bring about improvements in part of a service that you think may not up to standard.
The James Lind Alliance ….. the story so far. NICE Conference Tackling Health Priorities 7 th December 2006.
The Turnaround Challenge Workshop in SWF, 5 December 2012.
Life after Stroke in Scotland Nursing, Midwifery and Allied Health Professions Research Unit.
A Research Active Hospice
Islington Reaching Communities Briefing 01/12/2014
The James Lind Alliance Tackling treatment uncertainties together Lester Firkins, John Scadding and Mark Fenton INVOLVE Conference 2006.
Integration of Adult Health and Social Care VHS Member event, Monday 1 July Grant Hughes, Scottish Government
Cochrane Agenda and Priority Setting Methods Group (CAPSMG)
M.E. Research and Practice conference at Hove Town Hall 7 October 2014 Slides from Sonya Chowdhury and Mary Jane Willows’ presentations, part two.
Creating a service Idea. Creating a service Networking / consultation Identify the need Find funding Create a project plan Business Plan.
Co-designing a Patient & Public Involvement work plan t: w:
Emerging Latino Communities Initiative Webinar Series 2011 Advanced Board Development Training June 22, 2011 Presenter: Janet Hernandez, Capacity-Building.
Planning and submitting a shadow report Charlotte Gage Women’s Resource Centre.
An introduction to the JLA. What will I cover? What is the James Lind Alliance (JLA)? What do we do? How do we do it? What difference does it make?
Completing Club Activity Section (or How to Make Your Job Easier & More Effective)
Hey, I am Just a Volunteer! January Introduction. The National Member Services Committee has developed a series of National Education Seminars to.
An introduction to the JLA Katherine Cowan. What will I cover? What is the James Lind Alliance (JLA)? What do we do? How do we do it? What difference.
Components of a successful grant application Ann Crosland
Commissioning Self Analysis and Planning Exercise activity sheets.
Canadian English LING 202, Fall 2007 Dr. Tony Pi Research Ethics.
What to Expect During Your Support Needs Interview Orientation Session for Individuals with Disabilities and Families.
Welcome! Seminar Series: International comparisons about mortality data in people with intellectual disabilities.
Welcome and thanks for coming! 1 Created By C. Standerwick Patient Participation Group Lower Clapton Group Practice.
BHIVA PROMS / PREMS PROJECT A Community Consultation.
Public Administration Reform and Anti-Corruption Community of Practice SURVEY RESULTS Europe and the CIS May 2005.
James Lind Alliance Tackling treatment uncertainties together James Lind,
“What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.
Transforming Patient Experience: The essential guide
ISLLC Standard #1 Implementing a Shared Vision Name Workshop Facilitator.
Consent & Vulnerable Adults Aim: To provide an opportunity for Primary Care Staff to explore issues related to consent & vulnerable adults.
What is motor neurone disease? A fatal, rapidly progressive disease that affects the brain and spinal cord. Attacks the nerves that control movement so.
How can research be better informed by the direct involvement of the autistic community and broader autism community? Richard Mills July
Open to all: the role of public involvement in health research Faculty of Health and Social Care, Open University, Wednesday 9 th December 2015 Simon Denegri,
Project Work Plan - Manchester JSNA National Dataset Project Workshop 3 London, 28 th May 2009 Neil Bendel Manchester Joint Health Unit.
NIHR Themed Call Prevention and treatment of obesity Writing a good application and the role of the RDS 19 th January 2016.
RaDaR Rare Disease Registry Melanie Dillon RaDaR Project Facilitator.
The School Council President - tips to increase your effectiveness.
10 STEPS TO SET-UP A SUSTAINABLE TELECENTRE 16 September 2015 CAMBODIA.
Requirements in the product life cycle Chapter 7.
Sarah E. Shannon, PhD, RN. Slide 2 Ethics: Forgoing Medical Therapy TNEEL-NE Introduction Nurses are perceived as having a crucial “in-between” role:
Middle Managers Workshop 2: Measuring Progress. An opportunity for middle managers… Two linked workshops exploring what it means to implement the Act.
How to use this toolkit – A guide This toolkit is intended for use with groups or with individuals on a one to one basis, who may wish/be unable to respond.
Cochrane Agenda and Priority Setting Methods Group (CAPSMG)
Defining future research priorities: Results of the UK Kidney Transplant Priority Setting Partnership Simon Knight Academic.
Patient, Carer and Public Involvement and Engagement in Anaesthesia Research National Institute for Academic Anaesthesia Health Services Research Centre.
The James Lind Alliance
The Good, the bad and the ugly
Academic representative Committee CHAIR training
@hrbtmrn Intro and welcome.
Linking assurance and enhancement
Ten Key Trials in Cardiovascular Surgery
A brief introduction to the James Lind Alliance
YouGov polling on public priorities for Council spending
Strategy
Developing a User Involvement Strategy.
Arthritis and Musculoskeletal Alliance
Leeds Engagement Hub Chris Bridle – Engagement Manager
Presentation transcript:

Patient and public involvement (PPI) in setting the research agenda Dr Noémi Roy Oxford Molecular Haematology

What is the research agenda? This is the topics that funding bodies accept as being reasonable, valid and worthy of funding in each field It is partly dictated by researchers’ own interests (intellectual), drug companies’ interests (financial!) and to a certain extent some political guidance (eg Government putting extra funding into dementia research)

Why should patients be involved? Ethical reasons: democracy, accountability, empowerment Because patients are the ultimate beneficiaries of the research, involving them in setting the topics increases the RELEVANCE, the VALIDITY and the QUALITY of the research

How can patients be involved? This can de done through a PSP (priority setting partnership), which brings together patients/carers and clinicians in a structured way (eg through a JLA partnership- see later) A list of “top 10 topics” is created at the end of the PSP

Does this actually make a difference? More and more, funding bodies will look at the topics selected by a PSP and if a research proposal is asking for money and the topic is not one of the “Top 10” chosen by the PSP, it will be very difficult for it to get funded. This ensures the “Top 10” topics really do get money channeled to them

What is the JLA? This is the James Lind Alliance. What the JLA does: The JLA facilitates Priority Setting Partnerships. These bring patients, carers and clinicians together to identify and prioritise for research the treatment uncertainties which they agree are the most important. The JLA believes that: – addressing uncertainties about the effects of treatments should become accepted as a much more routine part of clinical practice – patients, carers and clinicians should work together to agree which, among those uncertainties, matter most and thus deserve priority attention

(Out of interest, who was James Lind??) Who was James Lind: The James Lind Alliance (JLA) is named after a pioneer of clinical trials, James Lind. Two hundred and fifty years ago, there were many conflicting ideas and unanswered questions about how to treat the deadly disease scurvy. James Lind – a Scottish naval surgeon – decided to confront this uncertainty by treating his patients within a clinical trial comparing six of the proposed remedies. His trial showed that oranges and lemons were dramatically better than the other supposed treatments.

How long does it take? The time scale for a Priority Setting Partnership will vary depending on scope and resources. Normally the process will usually take between 12 and 18 months to complete.

What about rare anaemias? We in Oxford are setting up a JLA PSP to try to identify the top 10 priorities for patients with rare inherited anaemias, and the clinicians looking after them We will work with clinicians all over the UK, and with as many patient groups as are willing to get on board

How does it work? The Priority Setting Partnership is led by a steering group. This has clinicians and patient representatives on it. Using the JLA’s guidance, the groups sets out how it will collect the data- paper surveys, online forms, face-to-face workshops, etc After the surveys have been filled in and the workshops completed, all of the data is looked at by the data handler

How does it work? The data handler looks at all the responses and groups similar responses together into different questions Once all the different questions are clearly set out, patient representatives and clinicians together agree on the “Top Ten” questions that they feel research should focus on The steering committee publicises the results to funding bodies and participants

What about DBA UK? You are the largest support group of any type of inherited anaemias in the UK You have an excellent track record of interest in research and patient advocacy You are very organised and have regular activities with your members

Now what? We would be interested in: – Having someone from your Committee on our PSP Steering Committee – Talking to your members at the Family Weekend about PPI and the JLA partnership we are setting up – Sending the surveys to your members – Holding workshops with some of your members (eg at the adult meeting)

Any questions? Please don’t hesitate to contact me: